Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1987-04-17
1989-08-22
Sutto, Anton H.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514303, 544277, 546118, A61K 3152, A61K 31435, C07D47334, C07D47102
Patent
active
048596779
ABSTRACT:
Compounds of the formula (I) ##STR1## wherein X is .dbd.N-- or .dbd.CH-- and physiologically acceptable salts and solvents thereof which have antiviral activity, a process for the preparation of the compounds and intermediates thereof, pharmaceutical compositions containing the compounds and a method for inhibiting the propagation of virus using the compounds.
REFERENCES:
patent: 3825541 (1974-07-01), Vince
patent: 3917837 (1975-11-01), Lin et al.
patent: 4199574 (1980-04-01), Schaeffer
patent: 4321376 (1982-03-01), Otani et al.
patent: 4423218 (1983-12-01), Otani et al.
patent: 4613666 (1986-09-01), Fukukawa et al.
Arita, et al., "J. Am. Chem. Soc.", vol. 105, No. 12, pp. 4049-4055 (1983).
Keller, et al., "Biological Methylation and Drug Design", The Humana Press, 1986, pp. 385-396.
Matuszewska, et al., Journal of Biological Chemistry, vol. 262(1), pp. 265-268, 01/05/87.
Hasobe, et al., Antimicrobial Agents and Chemotherapy, vol. 31(1), pp. 1849-1851, Nov. 1987.
Hasobe, et al., Molecular Pharmacology, vol. 33, pp. 713-720 (1988).
Fisher, et al., Journal of Antibiotics, vol. 40(6), pp. 873-881 (06/87).
Trost, et al., Chemical Abstracts, vol. 108, No. 7, 56522n (1988).
Borcherding, et al., Chemical Abstracts, vol. 107(25):237204k, (1987), Abstract of J. Org. Chem., vol. 52(54), pp. 5457-5461 (1987).
Hasobe, et al., Chemical Abstracts, vol. 108(5):31319p (1987), Abstract of Antimicrob. Agents Chemother., vol. 31(11), pp. 1849-1851 (1987).
Narayanan, et al., Chemical Abstracts, vol. 108(11):90734t (1988), Abstract of J. Med. Chem., vol. 31(3), pp. 500-503 (1988).
Akimoto et al., J. Med. Chem., 29, 1749-1753 (1986).
Beer et al., Helvetica Chimica Acta, vol. 65, 2570-2582 (1982).
Chamberlin et al., J. Org. Chem., 50, 4425-4431 (1985).
De Clercq, Antimicrobial Agents and Chemotherapy, vol. 28, No. 1, 84-89 (Jul. 1985).
Guthrie et al., J. Chem. Soc., 853-854 (1959).
Haines et al., J. Med. Chem., 30, 943-947 (1987).
Hua et al., J. Med. Chem., 30, 198-200 (1987).
Hudlicky et al., American Chemical Society Div. of Organic Chem., 193rd ACS Natl. Meeting, Denver, CO, Apr. 5-10, 1987.
Iwakawa et al., Can. J. of Chem., 56, 326-335 (1978).
Johnson et al., J. Am. Chem. Soc., 108, 5655-5656 (1986).
Krenitsky et al., J. Med. Chem., 29, 138-143 (1986).
Phadtare et al., J. Med. Chem., 30, 437-440 (1987).
Borchardt Ronald T.
Borcherding David R.
Rivers Diana G.
Sutto Anton H.
University of Kansas
LandOfFree
Nucleoside analogues having antiviral activity does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nucleoside analogues having antiviral activity, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nucleoside analogues having antiviral activity will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2417839